The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy

Natalizumab is a monoclonal antibody against α4-integrin approved for the treatment of multiple sclerosis (MS) due to a positive effect on clinical and magnetic resonance imaging (MRI) outcome measures. However, one relatively rare but serious side effect of this drug is a higher risk of developing...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis Vol. 19; no. 14; pp. 1826 - 1840
Main Authors: Wattjes, Mike P, Richert, Nancy D, Killestein, Joep, de Vos, Marlieke, Sanchez, Esther, Snaebjornsson, Petur, Cadavid, Diego, Barkhof, Frederik
Format: Journal Article
Language:English
Published: London, England SAGE Publications 01.12.2013
Sage Publications
Sage Publications Ltd
Subjects:
ISSN:1352-4585, 1477-0970, 1477-0970
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first